Human Anti-Human CXCR4 Recombinant Antibody (TAB-H72) (CAT#: TAB-H72)

Recombinant human antibody to Human CXCR4

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA

Figure 1 SIA induction by Ulocuplumab (BMS-936564) is CXCR4 specific as observed in Ramos and primary CLL cells but not in K562.

Figure 1 SIA induction by Ulocuplumab (BMS-936564) is CXCR4 specific as observed in Ramos and primary CLL cells but not in K562.

Ramos and K562 cell lines were treated with different concentrations of Ulocuplumab (BMS-936564) and AMD3100 for 48 hrs followed by running the samples on flow cytometer to study the % SIA. Treatment with AMD3100 in Ramos/ K562/CLL did not induce significant % SIA as compared to Ulocuplumab (BMS-936564). In contrast, Ulocuplumab (BMS-936564) induced significant % SIA in Ramos and CLL cells (CXCR4+), but not in K562 (CXCR4-) as evaluated by flow cytometry).

Kashyap, M. K. , Kumar, D. , Jones, H. , Amayachanaga, C. I. , Choi, M. Y. , & Melocardenas, J. , et al. (2016). Ulocuplumab (bms-936564 / mdx1338): a fully human anti-cxcr4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. Oncotarget, 7(3), 2809-2822.

Figure 2 SIA induction by Ulocuplumab (BMS-936564) is CXCR4 specific as observed in Ramos and primary CLL cells but not in K562.

Figure 2 SIA induction by Ulocuplumab (BMS-936564) is CXCR4 specific as observed in Ramos and primary CLL cells but not in K562.

The CLL cells cultured either alone or with stromal cell support were treated with Ulocuplumab (BMS-936564) or AMD3100 for 48 hrs at 37 o C followed by flow cytometer for measurement of % SIA. AMD3100 does not induce significant % SIA in CLL as compared to Ulocuplumab (BMS-936564). Ulocuplumab (BMS-936564) induced significant amount of % SIA in CLL cells alone or CLL co-cultured with stromal cell support.

Kashyap, M. K. , Kumar, D. , Jones, H. , Amayachanaga, C. I. , Choi, M. Y. , & Melocardenas, J. , et al. (2016). Ulocuplumab (bms-936564 / mdx1338): a fully human anti-cxcr4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. Oncotarget, 7(3), 2809-2822.


Specifications

  • Host Species
  • human
  • Derivation
  • human
  • Type
  • IgG4 - kappa
  • Specificity
  • CXCR4(chemokine (C-X-C motif) receptor 4, fusin, stromal cell-derived factor 1 receptor, SDF-1 receptor, CXCL12 receptor, CD184) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA, ICC
  • MW
  • 146.2 kDa
  • Related Disease
  • Acute myeloid leukemia (AML)

Product Property

  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.

Applications

  • Application Notes
  • The CXCR4 antibody has been reported in applications of FC, Cyt, WB, IHC, RT-PCR, IF, MTT.
    WB: Cells were harvested and lysed using lysis buffer supplemented with 5 mM NaF, 2 mM Na3VO4, 1 mM PMSF (polymethylsulfonylfluoride), 5 mg/ml leupeptin, and 5 mg/ml aprotinin.
    IHC: Autopsy specimens of synchronous secondary extramedullary MM sites wereanalyzed for the expression of CD138 and CXCR4. Murine BM tissues (femurs)were analyzed for the expression of human CD138 and stained with hema-toxylin-eosin.

Target

  • Alternative Names
  • FB22; HM89; LAP3; LCR1; NPYR; WHIM; CD184; LAP-3; LESTR; NPY3R; NPYRL; WHIMS; HSY3RR; NPYY3R; WHIMS1; D2S201E

Related Resources

  • Biosimilar Overview
Please refer to Ulocuplumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ulocuplumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CXCR4"

Select a product category from the dropdown menu below to view related products.
Please select product type
Mouse Antibody Products Human Antibody Products Humanized Antibody Products IgG Antibody Products Chicken IgY Antibody Products Neutralizing Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products ScFv Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-H72. Click the button above to contact us or submit your feedback about this product.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-H72, RRID: AB_3112044)

Copy citation

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare